+
Site Tour

Search

Showing 31 - 40 of 464 results.

  • EPIC™ Max Features

    PORCINE LEAFLETS LOW AORTIC PROTRUSION UNIQUE PERICARDIAL S

  • Clinical Data

    EXCELLENT OUTCOMES IN CLINICAL TRIAL RESULTS LEARN MORE: CLINICAL INSIGHTS  TAVI in Small Annulus 30-DAY NAVITOR™1,2 N=120 EVOLUT‡ PRO3 N=60 ACURATE NEO

  • Overview

    WATCH ON-DEMAND​: TAVI Webinar 2025  TAVI SUMMIT 2024  TAVI SUMMIT 2023 WATCH THE LIVE CASES: LIVE CASE FROM EACTS TECHNO-COLLEGE  LIVE CASE FROM RIGSHOSPITALET C

  • Clinical Data

    Tendyne™ TMVR improves your patients’ function and quality of life, with clinically significant improvement in a 6-minute walk test2 and Kansas City Cardiomyopathy Questionnaire (KCCQ) scores.1 The

  • Patients who benefit

    PATIENTS WHO BENEFIT MR IS THE MOST COMMON VALVULAR HEART DISEASE AND IS SIGNIFICANTLY UNDERTREATED3 More patients are suffering from MR than any other valve disease, and only a small percentage

  • Diagnosis

    PATENT DUCTUS ARTERIOSUS LEARN MORE: PATIENTS WHO BENEFIT

  • Overview

    LEARN MORE: AMPLATZER™ DUCT OCCLUDERS   AMPLATZER™ PICCOLO™ OCCLUDER WATCH ON-DEMAND:​ PDA Symposium 2024 If PDA is left untreated, the mortality rate is 20% by age 20 years,

  • Prevention

    AF AND THE CHALLENGES OF MEDICATION Many patients at risk of stroke want an alternative to oral anticoagulants (OACs), for example, warfarin and non-vitamin K oral anticoagulants (NOACs).7 40% Do N

  • Diagnosis

    AF AND STROKE ARE OFTEN CONNECTED MORE SEVERE LEARN MORE: PATIENTS WHO BENEFIT Clinical Data

  • Diagnosis

    Characteristics that are strongly associated with a causal role of PFO in an ischemic stroke of unknown cause are:9 Atrial septal aneurysm (ASA) and/or a moderate-to-severe shunt Atrial septal

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline